JUL 10, 2018 4:10 PM PDT

Reducing Cholesterol with Gene Editing

WRITTEN BY: Carmen Leitch

Scientists know that there is a link between a protein called PCSK9 and cholesterol; when the protein is not active, cholesterol levels go down. Therapies that aim to use this relationship to the patient’s advantage have focused on inhibiting drugs. A new study has used gene editing to inactivate the protein in rhesus macaque monkeys; the researchers were able to successfully lower cholesterol levels in those monkeys. This work, reported in Nature Biotechnology, may open up new approaches for treating patients with heart disease that cannot take PCSK9 inhibitors, which are often used to control high cholesterol.

Pictured is a cholesterol-filled atherosclerotic coronary artery from a human body. /Credit: Courtesy: University of Pennsylvania School of Medicine

In healthy people, PCSK9 can stop receptors from taking up excess bad cholesterol, called LDL, in the liver. It’s been found that drugs that inhibit the PCSK9 protein can lower cholesterol in people. However, some people with a severe type of cardiovascular disease called hypercholesterolemia cannot take these drugs. This research has shown that gene editing may be helpful for these cases.

"Most often these patients are treated with repeated injections of an antibody to PCSK9," noted first author Lili Wang, Ph.D., a research associate professor of Medicine. "But, our study shows that with successful genome editing, patients who cannot tolerate inhibitor drugs might no longer need this type of repeat treatment."

A Durham, NC biotech called Precision Biosciences coauthored this work. They created an enzyme that could recognize PCSK9, and inactivate it. The enzyme, called a meganuclease, was used along with a molecular tool called an adeno-associated virus (AAV) to target the therapeutics to the liver of the primate research model.

In animals that were exposed to middle- and high-dose AAV vectors, the levels of PCSK9 were reduced from 30 to 60 percent. The AAV vector that was used in this study has been shown in clinical trials to be safe and effective.

"Our initial work with several delivery and editing approaches produced the most impressive data in non-human primates when we paired AAV for delivery with the engineered meganuclease for editing," said senior author James M. Wilson, MD, Ph.D., a professor of Medicine and Pediatrics and director of the Gene Therapy Program at Penn. "We leveraged our 30-plus years of experience in gene therapy to progress the translational science of in vivo genome editing, and in doing so, reinforced the importance of early studies in nonhuman primates to assess safety and efficacy."

The researchers want to be sure that any gene edits they make in patients are limited to the PCSK9 gene. They also need to monitor for effects on the immune system. This work will hopefully help those suffering not only from hypercholesterolemia but a variety of metabolic diseases caused by gene mutations, and which affect the liver.

 

Sources: AAAS/Eurekalert! Via Penn Medicine News, Nature Biotechnology

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
JAN 11, 2020
Genetics & Genomics
JAN 11, 2020
Single Cells Carry 'Forests' of Chromatin
Researchers are learning more about how every human cell organizes and packages about two meters of DNA....
JAN 14, 2020
Genetics & Genomics
JAN 14, 2020
Genetic Study Reveals Drug Targets for Several Diseases
Some genetic mutations are due to a change in only one base of the genetic code, while others involve large regions of the genome....
FEB 08, 2020
Microbiology
FEB 08, 2020
Novel Coronavirus Has Now Infected At Least 34,500 People
In China, authorities are still struggling to contain the new coronavirus that emerged in the city of Wuhan and has since spread around the globe....
FEB 22, 2020
Genetics & Genomics
FEB 22, 2020
46,000-Year-Old Bird Recovered From Siberian Permafrost
In 2018 in a place called Belaya Gora in northeastern Siberia, a frozen bird was found in the ground. A sample of DNA was recovered from the bird....
MAR 03, 2020
Cell & Molecular Biology
MAR 03, 2020
New CRISPR-HOT Technique Can Color Cells and Genes
Since the CRISPR/Cas9 editing tool was developed several years ago, many scientists have modified and improved it for different applications....
MAR 17, 2020
Genetics & Genomics
MAR 17, 2020
Targeting RNA With CRISPR
Researchers screened thousands of target molecules to find the most effective targets, and have made their data openly available....
Loading Comments...